A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
作者
Richard D. Carvajal,Michael K. Wong,John A. Thompson,Michael S. Gordon,Karl D. Lewis,Anna C. Pavlick,Jedd D. Wolchok,Patrick B. Rojas,Jonathan D. Schwartz,Agop Y. Bedikian